newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.
biotech/news//FinanzNachrichten
Absci climbs after New Outperform at Leerink on catalyst path.Absci outlines ABS-201 interim 13-week data in H2 2026.
Veru shares rose after announcing a collaboration with Novo Nordisk.
KEY POINTS
Health Catalyst gained following the divestment of its revenue workflow and analytics software business.
Absci shares climbed after Leerink assigned a new Outperform rating, citing its catalyst path.
Alvotech has resubmitted its Biologics License Applications (BLAs) to the FDA.
05:00Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA...REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business...
► Artikel lesenDoAbsci climbs after New Outperform at Leerink on catalyst path08.05.Absci outlines ABS-201 interim 13-week data in H2 2026 while adding ABS-202 and funding plans into H1 202805:00Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA...REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business...
► Artikel lesen